HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tianwen Wu Selected Research

CRISPR-Associated Proteins

6/2022Enhancing Animal Disease Resistance, Production Efficiency, and Welfare through Precise Genome Editing.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tianwen Wu Research Topics

Disease

2Cognitive Dysfunction
01/2018 - 01/2015
2Memory Disorders (Memory Loss)
01/2017 - 01/2015
2Alzheimer Disease (Alzheimer's Disease)
01/2015 - 01/2015
1Disease Resistance
06/2022
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Epilepsy (Aura)
01/2021
1Hypertrophy
01/2021
1Glucose Intolerance
01/2021
1Inflammation (Inflammations)
01/2021
1Obesity
01/2021
1Neuroinflammatory Diseases
10/2019
1Mood Disorders (Mood Disorder)
01/2019
1Ischemia
01/2017

Drug/Important Bio-Agent (IBA)

2Cholinergic Agents (Cholinergics)IBA
10/2019 - 01/2017
1CRISPR-Associated ProteinsIBA
06/2022
1LipidsIBA
01/2021
116S Ribosomal RNAIBA
01/2021
1Biological ProductsIBA
01/2021
1Malondialdehyde (Propanedial)IBA
10/2019
1Acetylcholine (Acetylcholine Chloride)FDA Link
10/2019
1AcetylcholinesteraseIBA
10/2019
1Cisplatin (Platino)FDA LinkGeneric
10/2019
1Glutathione PeroxidaseIBA
10/2019
1Superoxide DismutaseIBA
10/2019
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2019
1Interleukin-10 (Interleukin 10)IBA
10/2019
1Reactive Oxygen Species (Oxygen Radicals)IBA
10/2019
1GlucocorticoidsIBA
01/2019
1harpagosideIBA
01/2018
1PolyphenolsIBA
01/2017
1CurcuminIBA
01/2015
1Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2015
1Proteins (Proteins, Gene)FDA Link
01/2015
1Amyloid (Amyloid Fibrils)IBA
01/2015

Therapy/Procedure

1Therapeutics
01/2021
1Oral Administration
01/2017